Induction of experimental primary and secondary antiphospholipid syndromes in naive mice
- PMID: 1285883
- DOI: 10.1111/j.1600-0897.1992.tb00796.x
Induction of experimental primary and secondary antiphospholipid syndromes in naive mice
Abstract
In the current series of experimental studies we show that anticardiolipin antibodies (ACA) are pathogenic: Infusion of serum ACA to the tail vein of naive mice induces experimental antiphospholipid syndrome (APLS) characterized by thrombocytopenia, prolonged aPTT, and recurrent fetal resorptions. Similar experimental APLS is induced by active immunization with serum as well as with natural human monoclonal ACA. APLS is also associated with low fecundity rate. The experimental APLS models were employed to demonstrate the efficacy of aspirin, low molecular heparin, and interleukin-3 preventing recurrent fetal loss. In another experiment, immunization with human monoclonal anti-DNA antibody was followed by the induction of APLS secondary to experimental systemic lupus erythematosus (SLE). In all studies, IgGs were found to be more pathogenic than IgMs ACA. These studies confirm the autoimmune nature of APLS.
Similar articles
-
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).J Clin Invest. 1992 May;89(5):1558-63. doi: 10.1172/JCI115749. J Clin Invest. 1992. PMID: 1569194 Free PMC article.
-
Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.J Autoimmun. 1992 Aug;5(4):495-509. doi: 10.1016/0896-8411(92)90008-e. J Autoimmun. 1992. PMID: 1418290
-
Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.J Clin Immunol. 1993 Mar;13(2):127-38. doi: 10.1007/BF00919269. J Clin Immunol. 1993. PMID: 7686561
-
Role of IL-3 in the antiphospholipid syndrome.Lupus. 1994 Aug;3(4):259-61. doi: 10.1177/096120339400300410. Lupus. 1994. PMID: 7804312 Review.
-
Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).Haemostasis. 1994 May-Jun;24(3):165-74. doi: 10.1159/000217098. Haemostasis. 1994. PMID: 7988946 Review.
Cited by
-
Treatment of the antiphospholipid syndrome.Clin Rev Allergy Immunol. 1995 Spring;13(1):73-89. doi: 10.1007/BF02772251. Clin Rev Allergy Immunol. 1995. PMID: 7648352 Review. No abstract available.
-
Preventing antiphospholipid antibody-induced fetal loss: a new idea.J Clin Invest. 1993 Apr;91(4):1267. doi: 10.1172/JCI116323. J Clin Invest. 1993. PMID: 8473480 Free PMC article. No abstract available.
-
Idiotypic network, pathogenic autoantibodies and autoimmunity.Clin Exp Immunol. 1995 Jul;101 Suppl 1(Suppl 1):26-8. doi: 10.1111/j.1365-2249.1995.tb06159.x. Clin Exp Immunol. 1995. PMID: 7606856 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources